William R. Jellison - 20 Jun 2025 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: Director
Signature: /s/ William R. Jellison
Issuer symbol: ANIK
Transactions as of: 20 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 24 Jun 2025, 17:12:27 UTC
Previous filing: 02 May 2025
Next filing: 02 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jellison William R	Director	32 WIGGINS AVENUE, BEDFORD	/s/ William R. Jellison	24 Jun 2025	0001189883

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Award	$0	+14,164	+227%	$0.000000	20,403	20 Jun 2025	Direct	F1
holding	ANIK	Common Stock						2,700	20 Jun 2025	Revocable Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026.
F2	Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee.